Digital Technology Characteristics of Families with Children with Asthma
Sunday, April 30, 2023
11:15 AM – 11:30 AM ET
Location: Convention Center: 204 C
Publication Number: 2375.2
Kristin Kan, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; Avani Shah, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; Emily R. Simmons, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; Luis Morales, Stanford University School of Medicine, San Francisco, CA, United States; Leonardo Barrera, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; Greta List, Brown University, Chicago, IL, United States; Ruchi Gupta, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
Presenting Author(s)
Kristin Kan, MD, MPH, MSc (she/her/hers)
Assistant Professor Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Disclosure(s):
Kristin Kan, MD, MPH, MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Avani Shah, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Emily R. Simmons, MSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Luis Morales, M.A.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Leonardo Barrera, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Greta List, n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ruchi Gupta, MD, MPH: Aimmune (Ongoing) (Products/Services: Advisory Committee); Allergenis (Ongoing) (Products/Services: Advisory Committee); Food Allergy Research & Education (FARE) (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Genentech (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Melchiorre Family Foundation (Terminated, August 31, 2021) (Products/Services: Research Support including clinical trials & the principal or named investigator); National Institutes of Health (NIH) (R21 ID # AI135705, R01 ID # AI130348, U01 ID # AI138907) (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novartis (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Sunshine Charitable Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); The Walder Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Yobee Care, Inc (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)